Trial Profile
Once Daily Versus Conventional Dosing of Asacol [mesalazine] in the Maintenance of Quiescent Ulcerative Colitis: A Randomized Pilot Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2013
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 30 Sep 2009 New trial record.